Literature DB >> 28435172

Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

H Stepan1, S Kuse-Föhl1, W Klockenbusch2, W Rath3, B Schauf4, T Walther5, D Schlembach6.   

Abstract

Purpose: Official guideline published and coordinated by the German Society of Gynecology and Obstetrics (DGGG). Hypertensive pregnancy disorders contribute significantly to perinatal as well as maternal morbidity and mortality worldwide. Also in Germany these diseases are a major course for hospitalization during pregnancy, iatrogenic preterm birth and long-term cardiovascular morbidity.
Methods: This S1-guideline is the work of an interdisciplinary group of experts from a range of different professions who were commissioned by DGGG to carry out a systematic literature search of positioning injuries. Members of the participating scientific societies develop a consensus in an informal procedure. Afterwards the directorate of the scientific society approves the consensus. Recommendations: This guideline summarizes the state-of-art for classification, risk stratification, diagnostic, treatment of hypertensive pregnancy disorders.

Entities:  

Keywords:  HELLP syndrome; hypertension; preeclampsia

Year:  2015        PMID: 28435172      PMCID: PMC5396549          DOI: 10.1055/s-0035-1557924

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  216 in total

1.  Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.

Authors:  François Audibert; Isabelle Boucoiran; Na An; Nikolai Aleksandrov; Edgard Delvin; Emmanuel Bujold; Evelyne Rey
Journal:  Am J Obstet Gynecol       Date:  2010-08-05       Impact factor: 8.661

Review 2.  Uterine artery Doppler in first-trimester pregnancy screening.

Authors:  Ray O Bahado-Singh; Cristiano Jodicke
Journal:  Clin Obstet Gynecol       Date:  2010-12       Impact factor: 2.190

Review 3.  Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review.

Authors:  Shakila Thangaratinam; Corine M Koopmans; Shalini Iyengar; Javier Zamora; Khaled M K Ismail; Ben W J Mol; Khalid S Khan
Journal:  Acta Obstet Gynecol Scand       Date:  2011-04-15       Impact factor: 3.636

Review 4.  Contemporary prediction of preeclampsia.

Authors:  Elena Scazzocchio; Francesc Figueras
Journal:  Curr Opin Obstet Gynecol       Date:  2011-04       Impact factor: 1.927

5.  Combined screening for preeclampsia and small for gestational age at 11-13 weeks.

Authors:  Leona C Y Poon; Argyro Syngelaki; Ranjit Akolekar; Jonathan Lai; Kypros H Nicolaides
Journal:  Fetal Diagn Ther       Date:  2012-09-13       Impact factor: 2.587

6.  What is the optimal time for delivery in women with gestational hypertension?

Authors:  Meredith O Cruz; Weihua Gao; Judith U Hibbard
Journal:  Am J Obstet Gynecol       Date:  2012-06-11       Impact factor: 8.661

7.  Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.

Authors:  A T Papageorghiou; C K Yu; R Bindra; G Pandis; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2001-11       Impact factor: 7.299

8.  Long-term follow-up in patients with a history of (H)ELLP syndrome.

Authors:  M G van Pampus; H Wolf; G Mayruhu; P E Treffers; O P Bleker
Journal:  Hypertens Pregnancy       Date:  2001       Impact factor: 2.108

9.  Random urinary protein-to-creatinine ratio for prediction of significant proteinuria in women with preeclampsia.

Authors:  Waralak Yamasmit; Surasith Chaithongwongwatthana; Dhiraphongs Charoenvidhya; Boonchai Uerpairojkit; Jorge Tolosa
Journal:  J Matern Fetal Neonatal Med       Date:  2004-11

10.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.

Authors:  Fàtima Crispi; Carmen Domínguez; Elisa Llurba; Pilar Martín-Gallán; Luís Cabero; Eduard Gratacós
Journal:  Am J Obstet Gynecol       Date:  2006-03-20       Impact factor: 8.661

View more
  10 in total

1.  Influence of Preeclampsia on Induction of Labor at Term: A Cohort Study.

Authors:  Jutta Pretscher; Christel Weiss; Ulf Dammer; Florian Stumpfe; Florian Faschingbauer; Matthias W Beckmann; Sven Kehl
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Association of maternal home blood pressure trajectory during pregnancy with infant birth weight: the BOSHI study.

Authors:  Noriyuki Iwama; Mari S Oba; Michihiro Satoh; Takayoshi Ohkubo; Mami Ishikuro; Taku Obara; Satomi Sasaki; Masatoshi Saito; Yoshitaka Murakami; Shin-Ichi Kuriyama; Nobuo Yaegashi; Kazuhiko Hoshi; Yutaka Imai; Hirohito Metoki
Journal:  Hypertens Res       Date:  2020-03-10       Impact factor: 3.872

Review 3.  Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines.

Authors:  Rachel G Sinkey; Ashley N Battarbee; Natalie A Bello; Christopher W Ives; Suzanne Oparil; Alan T N Tita
Journal:  Curr Hypertens Rep       Date:  2020-08-27       Impact factor: 5.369

4.  Efficacy and safety of combination of magnesium sulfate, phentolamine and nifedipine in treatment of patients with hypertensive disorder complicating pregnancy.

Authors:  Jinggui Zhang; Jun Li
Journal:  Exp Ther Med       Date:  2019-08-30       Impact factor: 2.447

5.  Awareness of obstetricians for long-term risks in women with a history of preeclampsia or HELLP syndrome.

Authors:  Pilar Palmrich; Carina Binder; Harald Zeisler; Bettina Kroyer; Petra Pateisky; Julia Binder
Journal:  Arch Gynecol Obstet       Date:  2021-08-18       Impact factor: 2.344

6.  Postpartum Assessment of the Correlation between Serum Hormone Levels of Estradiol, Progesterone, Prolactin and ß-HCG and Blood Pressure Measurements in Pre-Eclampsia Patients.

Authors:  Mariz Kasoha; Zoltan Takacs; Jacob Dumé; Sebastian Findeklee; Christoph Gerlinger; Romina-Marina Sima; Liana Ples; Erich-Franz Solomayer; Bashar Haj Hamoud
Journal:  Diagnostics (Basel)       Date:  2022-07-12

Review 7.  The Hypertensive Disorders of Pregnancy: A Focus on Definitions for Clinical Nephrologists.

Authors:  Elisa Longhitano; Rossella Siligato; Massimo Torreggiani; Rossella Attini; Bianca Masturzo; Viola Casula; Ida Matarazzo; Gianfranca Cabiddu; Domenico Santoro; Elisabetta Versino; Giorgina Barbara Piccoli
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

8.  Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.

Authors:  Dietmar Schlembach; Martin Hund; Annabel Schroer; Cyrill Wolf
Journal:  BMC Health Serv Res       Date:  2018-08-06       Impact factor: 2.655

Review 9.  The Targeting of Nuclear Factor Kappa B by Drugs Adopted for the Prevention and Treatment of Preeclampsia.

Authors:  Agata Sakowicz
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

10.  The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.

Authors:  Nurul Afzan Aminuddin; Rosnah Sutan; Zaleha Abdullah Mahdy; Rahana Abd Rahman; Dian Nasriana Nasuruddin
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.